期刊文献+

检测TRAF-2在骨肉瘤细胞中的表达及三氧化二砷、VEGF对其表达的影响

The value of detecting TRAF-2 at human osteosarcoma SaOS-2 cell line and the expression affected by arsenic trioxide and VEGF
原文传递
导出
摘要 目的通过检测肿瘤坏死因子受体相关因子(TRAF-2)在骨肉瘤细胞表达的变化及三氧化二砷(As2O3)和血管内皮细胞生长因子(VEGF)对其表达的影响,探讨TRAF-2在骨肉瘤发病机制中的作用。方法人骨肉瘤Sa OS-2细胞经分别加入不同浓度的As2O3和(或)VEGF培养48 h后,采用实时荧光定量PCR法测定TRAF-2 mRNA的表达水平。结果 100 ng/ml浓度的VEGF能显著上调TRAF-2 mRNA的表达水平,差异有统计学意义(P<0.01),50 ng/ml以下浓度的VEGF对TRAF-2 mRNA的表达水平没有影响,差异无统计学意义(P>0.05);2μmol/L以上浓度的As2O3能显著下调TRAF-2 mRNA的表达水平,并能显著降低100 ng/ml浓度的VEGF对TRAF-2 mRNA表达水平的上调功能,差异有统计学意义(P<0.01);而1μmol/L浓度的As2O3对TRAF-2 mRNA的表达水平没有影响,并不影响100 ng/ml浓度的VEGF对TRAF-2 mRNA表达水平的诱导作用,差异无统计学意义(P>0.05)。结论 TRAF-2在骨肉瘤的发病机制中可能起重要作用,VEGF具有上调TRAF-2 mRNA表达水平的作用,而As2O3则起相反作用,两者具有一定的量-效关系。 Objective To explore the possible roles of tumor necrosis factor receptor-associated factor-2( TRAF-2) in the pathogenesis of osteosarcoma,and the effects of arsenic trioxide( As2O3)or vascular endothelial growth factor(VEGF) on human Sa OS-2 cell line were observed. Methods Human osteosarcoma Sa OS-2 cell line was cultured and treated with As2O3and(or) VEGF at different concentration. After 48 hours,real-time quantitative reverse transcription polymerase chain reaction(QRT-PCR) methods were used to investigate the level of TRAF-2 mRNA expression. Results The expression of TRAF-2 mRNA was significantly increased in Sa OS-2 cell line treated with VEGF at 100 ng / ml concentration,the difference had statistical significance( P〈0. 01),while no change of TRAF-2 mRNA expression was observed under 50 ng / ml concentration of VEGF( P〉0. 05). Moreover,it was significantly dicreased of TRAF-2 mRNA expression in Sa OS-2 cell line treated with As2O3 at 2 μmol / L concentration and more( P〈0. 01). Interesting,the inducing function of VEGF at 100 ng / ml concentration on the TRAF-2 mRNA expression can be inhibited significantly by As2O3 at this concentration( P〈0. 01). Whereas,no change of TRAF-2 mRNA expression was seen when treated whith As2O3 at 1 μmol / L concentration( P〉0. 05). In addition,As2O3 at 1 μmol / L concentration couldn't also affect the TRAF-2 mRNA expression in Sa OS-2 cell line treated with VEGF at 100 ng / ml concentration( P〉0. 05),the difference had no statistical significance. Conclusion TRAF-2 may paly an important role in the pathogenesis of osteosarcoma. The osteosarcoma cell proliferation can be promoted by VEGF and inhibited by As2O3 in a dose-dependent manner.
出处 《中国卫生检验杂志》 CAS 2015年第7期988-990,共3页 Chinese Journal of Health Laboratory Technology
基金 温岭市科技局基金资助项目(2013-1-64)
关键词 骨肉瘤 三氧化二砷 肿瘤坏死因子受体相关因子 血管内皮细胞生长因子 Osteosarcoma Arsenic trioxide Tumor necrosis factor receptor-associated factor 2 VEGF
  • 相关文献

参考文献3

二级参考文献30

  • 1郭卫,杨荣利,汤小东,唐顺,李大森,杨毅.成骨肉瘤新辅助化学药物治疗的疗效分析[J].中华医学杂志,2004,84(14):1186-1190. 被引量:25
  • 2方成,陈振光,喻爱喜,祝少博.三氧化二砷诱导骨肉瘤细胞凋亡的实验研究[J].中华骨科杂志,2003,23(6):345-348. 被引量:17
  • 3刘琳,赵伟,秦叔逵,李苏宜,邱少敏,王南瑶,陈惠英.三氧化二砷抗裸鼠人结肠癌移植瘤作用及其机制的研究[J].中国肿瘤临床,2005,32(18):1067-1070. 被引量:10
  • 4汤小东,郭卫,李大森.三氧化二砷诱导尤文肉瘤细胞凋亡及对EWS-FLi1融合蛋白的影响[J].中国肿瘤临床,2005,32(22):1280-1283. 被引量:1
  • 5Wittig JC, Bickels J, Priebat D, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician, 2002, 65 : 1123-1132.
  • 6Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br, 2002, 84: 88-92.
  • 7Meyers PA, Gorlick R, Heller G, et al. Intensification of Preoperative Chemotherapy for Osteogenic Sarcoma: Results of the Memorial Sloan-Kettering (T12) Protocol. J Clin Oncol, 1998, 16 :2452-2458.
  • 8Kushner BH, Meyem PA. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. J Clin Oncol, 2001, 19: 870-880.
  • 9Guo W, Healey JH, Meyers PA, et al. Mechanisms of Methotrexate Resistance in Osteosarcoma. Clin Cancer Res, 1999, 5:621-627.
  • 10Guo W, Zeng C, Dong F, et al. Paclitaxel-induced apoptosis in osteosarcoma cell line U-2 OS. Chin Med J ( Engl ), 2002, 115 :1796-1801.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部